MedTrace Logo

The Effect of Intrathecal Magnesium Sulfate on Shivering

NCT05427149 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-09-27

No results posted yet for this study

Summary

Shivering after spinal anesthesia is a common complication. Mangesium sulfate, which can be used intrathecally, is effective in preventing tremor. But what is the ideal dose?

Conditions

  • Magnesium Sulfate Causing Adverse Effects in Therapeutic Use
  • Postoperative Shivering
  • Cesarean Section Complications

Interventions

DRUG

25 mg MgSO4 (Magnezyum Sulfat %15, Biofarma, Istanbul, Turkey)

It will be evaluated whether there is postpinal shivering in the cases.

Sponsors & Collaborators

  • Yuzuncu Yıl University

    lead OTHER

Principal Investigators

  • NUREDDİN YUZKAT, Assoc. prof · VAN YUZUNCU YIL UNİVERSİTY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-10
Primary Completion
2022-06-30
Completion
2022-08-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05427149 on ClinicalTrials.gov